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Background: The pathophysiology of thyroid function on lipid and glucose metabolism and blood pressure
for subjects with thyroid disorder is well known; however, studies exploring the association between
thyroid function and components of metabolic syndrome (MetS) in elderly subjects with subclinical
thyroid dysfunction are limited. Our objectives were to investigate the prevalence of subclinical thyroid
dysfunction among the elderly and its relationship with MetS in Taiwan.
Methods: A total of 6,652 subjects aged 65 years or older were recruited during a routine health checkup
at four MJ Health Screening Centers in Taiwan. Gender; blood pressure; body mass index; and serum
levels of fasting glucose, total cholesterol (TC), high-density-lipoprotein cholesterol (HDL-C), low-
density-lipoprotein cholesterol, and triglyceride were compared between subjects with subclinical
hypothyroidism and hyperthyroidism.
Results: The overall prevalences of the MetS, subclinical hyperthyroidism, and subclinical hypothyroidism
were 30.4%, 6.0%, and 2.0%, respectively. The prevalence of subclinical thyroid dysfunction was signiﬁ-
cantly higher among women as compared with men (9.9% vs. 6.3%, respectively; p< 0.05). Male subjects
with subclinical hyperthyroidism had signiﬁcantly lower body mass index, systolic blood pressure, TC,
low-density-lipoprotein cholesterol, HDL-C, triglyceride, and number of MetS criteria than female
subjects. However, no signiﬁcant differences for each component of MetS, with the exception of TC and
HDL-C, were found between male and female subjects with subclinical hypothyroidism.
Conclusion: Subclinical thyroid dysfunction would present in about 8% of Taiwanese elderly, and about
one-third of them had MetS.
Copyright  2011, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Background
Subclinical thyroid dysfunction, deﬁned as thyroid-stimulating
hormone (TSH) levels outside the normal reference range with
normal thyroid hormone levels1, is associated with various adverse
cardiovascular outcomes, including atherosclerotic disease2,
altered total and low-density-lipoprotein cholesterol (LDL-C)3, and
atrial ﬁbrillation4. Subclinical hypothyroidism is classiﬁed as the
presence of elevated serum TSH levels with normal serum freef Internal Medicine, Cardinal
ng-Cheng Rd, Xindian, Taipei
erest.
iwan Society of Geriatric Emergenthyroxine (T4) concentrations, whereas subclinical hyperthy-
roidism is identiﬁed as low serum TSH levels with normal serum
levels of free T41.
The prevalence of subclinical hypothyroidism has been esti-
mated to be from 1.4% to 8%5e8, and the prevalence of subclinical
hyperthyroidism varies from 0.8% to 5.8%9,10. Variances in the
ethnic group analyzed, intake of iodine, and population age could
account for these discrepancies in prevalences; therefore, deter-
mining the prevalence of subclinical thyroid dysfunction in speciﬁc
populations is necessary. Because the aged population is growing
rapidly and globally, it is necessary to analyze the prevalence of
subclinical thyroid dysfunction among the elderly.
The metabolic syndrome (MetS) is a cluster of multiple cardio-
vascular risk factors, including central obesity, glucose intolerancecy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
C.-C. Lai et al.26or Type 2 diabetes, dyslipidemia, low high-density-lipoprotein
cholesterol (HDL-C), and hypertension11. Because cardiovascular
disease is the leading cause of death in both men and women older
than 65 years, prevention and early recognition of MetS in elderly
populations is an important public health issue that deserves more
attention.
The pathophysiology of thyroid function on lipid and glucose
metabolism and blood pressure for subjects with thyroid disorder is
well known3,12e14; associations between thyroid function and
parameters of MetS have been reported15e17. However, studies
exploring the association between thyroid function and compo-
nents of MetS in elderly subjects with subclinical thyroid dysfunc-
tion are limited. Therefore, the aim of the present study was to
investigate the prevalence of subclinical thyroid dysfunction among
an elderly population inTaiwan and its associationwithMetS in this
speciﬁc group.
2. Methods
2.1. Study population
Elderly subjects (65 years) were recruited during a routine
health checkup at theMJ Health Screening Center in Taipei. Subjects
were excluded from the analyses if theywere takingmedications for
control of glucose, blood pressure, dyslipidemia, and thyroid func-
tion. All the subjects were anonymous, and informed consent was
obtained from each of them. The data provided by the MJ Health
Screening Center was for research purpose only, and this investi-
gation was approved by the institutional review board of the MJ
Health Screening Center.
2.2. Laboratory measurements
After a 10-hour fasting, blood samples were drawn from an
antecubital vein for biochemical analysis. Plasmawas separated from
blood within 1 hour and stored at 30C and analyzed for fasting
plasma glucose (FPG), lipid proﬁles, and thyroid function. FPG was
detected using a glucose oxidase method and analyzer (YSI 203
glucose analyzer; Scientiﬁc Division, Yellow Spring Instruments,
Yellow Spring, OH, USA). Triglyceride (TG) was measured using the
dry, multilayer analytical slide method in the Fuji Dri-Chem 3000
analyzer (Fuji Photo Film, Minato-Ku, Tokyo, Japan). Serum HDL-C
concentration was analyzed using an enzymatic cholesterol assay
method after dextran sulfate precipitation. The total T4 was
measured by ﬂuorescence polarization immunoassay (Abbott Ax
system, Abbott, Chicago, USA; sensitivity 13.51 nmol/L, interassay
coefﬁcient of variation (CV)< 7.4%, and intra-assay CV< 8.6%). TSH
was measured by microparticle enzyme immunoassay (Abbott Ax
system, Abbott, Chicago, USA; sensitivity, 0.03 mU/L, CV< 5.0%, and
intra-assay CV< 5.3%).
2.3. Deﬁnitions
Subjects were evaluated for MetS using the National Cholesterol
Education Program Adult Treatment Panel III (ATP III) criteria11 with
modiﬁcations. Because waist circumferences were not available for
all subjects, a body mass index (BMI) greater than or equal to 27 kg/
m2 was used as a measure of obesity; this BMI was deﬁned by the
Taiwanese Department of Health as indicating obesity18. Four addi-
tional criteria included TG 150 mg/dL, elevated blood pressure
(130 mmHg systolic blood pressure or 85 mmHg diastolic blood
pressure), FPG concentration 100 mg/dL, and HDL-C 40 mg/dL
for men or 50 mg/dL for women11. Subjects who possessed at least
three out of ﬁve criteria met the deﬁnition of MetS11.The diagnosis of subclinical hypothyroidismwas made based on
elevated serum TSH levels (>5.00 mIU/mL) and normal thyroid
hormone levels, and subclinical hyperthyroidism was deﬁned as
lowTSH levels (<0.47 mIU/mL)with normal thyroid hormone levels.
2.4. Statistical analysis
Variables measured in this study were expressed as mean -
 standard deviation. Comparisons of continuous variables between
two groups were performed using independent-sample t tests
(Student’s t test). Categorical variables were presented as counts and
percentages and compared using the Chi-squared test. All statistical
analyses were performed with SPSS 12.0 software (SPSS Inc., Chi-
cago, IL,USA), anda pvalue less than0.05was considered statistically
signiﬁcant.
3. Results
3.1. Baseline characteristics of the study population
A total of 6,652 elderly subjects were included in this study, and
2,026 of them had MetS (Fig. 1). In addition, 398 and 131 subjects
had subclinical hyperthyroidism and hypothyroidism, respectively.
Therefore, the overall prevalences of the MetS, subclinical hyper-
thyroidism, and subclinical hypothyroidism were 30.5%, 6.0%, and
2.0%, respectively.
After separating the subjects by gender, 229 (6.3%)male subjects
and 300 (9.9%) female subjects had subclinical thyroid dysfunction.
The prevalence of subclinical thyroid dysfunction was signiﬁcantly
higher among female as compared with male subjects (9.9% vs.
6.3%, respectively; p< 0.05).
The prevalences of subclinical hypothyroidism among subjects
with and without MetS were 43 (2.1%) and 88 (1.9%), respectively
(p¼ 0.566). In contrast, the numbers of subjects with subclinical
hyperthyroidism among subjects with and without MetS were 112
(5.5%) and 286 (6.2%), respectively (p¼ 0.312).
As shown inTable 1, the clinical characteristics of all subjectswith
subclinical thyroid disease were analyzed. Subjects with subclinical
hyperthyroidism had signiﬁcantly lower total cholesterol (TC) and
TG than subjectswith subclinical hypothyroidism. Fig. 2 displays the
frequency of MetS and each metabolic component of MetS among
subjects with subclinical hyperthyroidism and hypothyroidism.
Subjects with subclinical hypothyroidism were more likely to have
elevated TG than those with subclinical hyperthyroidism.
3.2. Gender-speciﬁc comparisons in subjects with subclinical
hypothyroidism
Gender-speciﬁc differences in this study population were also
analyzed; 1.4% of male and 2.6% of female subjects had subclinical
hypothyroidism. The prevalence of subclinical hypothyroidism was
signiﬁcantly higher among women. Clinical characteristics of the
subclinical hypothyroidism group are shown in Table 2. No signiﬁ-
cant differences were observed for each metabolic parameter, with
the exception of TC (p¼ 0.002) and HDL-C (p< 0.001), which were
higher in the female subjects. Among subjects with subclinical
hypothyroidism, 43 (32.8%) had MetS. The subgroup with MetS had
signiﬁcantly higher TSH levels than those without MetS
(10.42 9.41 mIU/mL vs. 7.59 3.54 mIU/mL, p¼ 0.014).
3.3. Comparison of subjects with subclinical hyperthyroidism
according to gender
The prevalence of subclinical hyperthyroidism was determined
by gender; 5.9% of male and 6.1% of female subjects had subclinical
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Fig. 1. The distribution of study subjects.
Subclinical Thyroid Dysfunction and Metabolic Syndrome 27hyperthyroidism. No signiﬁcant differences were observed between
the prevalences of subclinical hyperthyroidism among women and
men (p¼ 0.795). As shown in Table 3, the clinical characteristics of
subjects with subclinical hyperthyroidism were analyzed. Men had
signiﬁcantly lower BMI, systolic blood pressure, TC, LDL-C, HDL-C,
TG, and number of MetS criteria. Furthermore, among 398 subjects
with subclinical hyperthyroidism, 112 (28.1%) had MetS.
4. Discussion
The present study found that the prevalences of subclinical
hyperthyroidism and hypothyroidism among 6,652 elderly subjects
were 6.0% and 2.0%, respectively, which is in contrast to those of
a previous study19 that reported a prevalence of subclinical
hyperthyroidism of 2.1% and subclinical hypothyroidism of 2.9%
using a community-based cross-sectional survey. Because the
prevalence of these disorders may be affected by the type of study
population, ethnicity, and dietary iodine intake20,21, the difference
between the present study and previous reports5e10,19 may result
from the speciﬁc population analyzed, the method of enrollment,
and strict inclusion criteria used.
The prevalences of subclinical thyroid dysfunction and hypothy-
roidism among female subjects were higher than those amongmaleTable 1
Comparison of elderly subjects with subclinical hypothyroidism and those with subclini
Variable Subclinical hypothyroidis
(n¼ 131)
Age (yr) 71.1 4.6
Body mass index (kg/m2) 23.8 3.4
Systolic blood pressure (mm Hg) 141.6 27.4
Diastolic blood pressure (mm Hg) 75.7 13.7
Total cholesterol (mg/dL) 214.4 43.0
LDL cholesterol (mg/dL) 133.0 41.1
HDL cholesterol (mg/dL) 48.3 16.5
Triglycerides (mg/dL) 148.5 99.2
Fasting blood glucose (mg/dL) 107.0 31.9
Number of metabolic syndrome criteria 2.0 1.1
TSH (mIU/mL) 8.5 6.2
HDL¼ high-density lipoprotein; LDL¼ low-density lipoprotein; TSH¼ thyroid-stimulatinsubjects in the present study, which is consistent with previous
reports7,8. Because subclinical thyroid dysfunction is not rare among
the elderlyand ismore common inwomen, it is necessary to evaluate
the thyroid function among elderly women to identify the possible
presence of subclinical thyroid dysfunction.
The association between subclinical thyroid hypo/hyperthy-
roidism and MetS was also evaluated; 32.8% of subjects with
subclinical hypothyroidism and 28.1% of subjects with subclinical
hyperthyroidism had MetS. In addition, elevated TG was more
frequently noted in subjects with subclinical hypothyroidism than in
those with subclinical hyperthyroidism. With respect to lipid
proﬁles, subjects with subclinical hyperthyroidism had signiﬁcantly
lower TC and TG levels as compared with subjects with subclinical
hypothyroidism, which is consistent with a previous study inwhich
TC was signiﬁcantly higher in Korean subjects with subclinical
hypothyroidism than those with subclinical hyperthyroidism
(p¼ 0.011), who were enrolled during a female medical checkup22.
All of the aforementioned ﬁndings suggest that subclinical hypo-
thyroidism would more adversely affect the lipid proﬁle and cause
MetS more frequently than subclinical hyperthyroidism.
We also examined each component of MetS among the subjects
with subclinical hypothyroidism; 65 (49.6%) had elevated blood
pressure and FPG, and 62 (47.3%), 25 (19.1%) and 46 (35.1%) subjectscal hyperthyroidism
m Subclinical hyperthyroidism
(n¼ 398)
p
69.8 4.5 0.005
23.8 3.5 0.99
138.4 23.4 0.19
75.4 12.4 0.88
203.8 39.4 0.009
132.0 33.9 0.772
47.8 14.1 0.733
123.0 69.0 0.001
107.2 33.3 0.954
1.8 1.2 0.155
0.3 0.1 <0.001
g hormone.
Table 3
Gender differences in elderly subjects with subclinical hyperthyroidism
Variable Male
(n¼ 178)
Female
(n¼ 220)
p
Age (yr) 70.0 4.4 69.7 4.6 0.563
Body mass index (kg/m2) 23.1 2.9 24.4 3.8 <0.001
Systolic blood pressure (mm Hg) 133.5 22.4 142.3 23.4 <0.001
Diastolic blood pressure (mm Hg) 74.9 12.2 75.9 12.5 0.434
Total cholesterol (mg/dL) 192.8 35.6 212.6 40.0 <0.001
LDL cholesterol (mg/dL) 126.7 31.6 136.3 35.1 0.005
HDL cholesterol (mg/dL) 44.9 12.9 50.2 14.6 <0.001
Triglycerides (mg/dL) 110.9 64.5 132.7 71.1 0.002
Fasting blood glucose (mg/dL) 105.0 29.3 108.9 36.2 0.25
Number of Metabolic syndrome criteria 1.6 1.1 2.1 1.2 <0.001
TSH (mIU/mL) 0.3 0.1 0.3 0.1 0.219
HDL¼ high-density lipoprotein; LDL¼ low-density lipoprotein; TSH¼ thyroid-
stimulating hormone.
Fig. 2. The frequency of each MetS component was analyzed between subjects with
subclinical hypothyroidism and hyperthyroidism. BMI¼ body mass index; BP¼ blood
pressure; FPG¼ fasting plasma glucose; HDL¼ high-density-lipoprotein;
MetS¼metabolic syndrome; TG¼ triglyceride.
C.-C. Lai et al.28had low HDL-C, high BMI, and high TG levels, respectively. These
ﬁndings are consistent with those of recent studies23,24, which
reported that subclinical hypothyroidism would affect each
component of MetS, including blood pressure and metabolism of
carbohydrates and lipids. Although levothyroxine replacement
therapy for subclinical hypothyroidism reversed the metabolic
abnormalities25,26, further clinical studies are necessary to evaluate
the long-term effects of thyroxine treatment for subclinical hypo-
thyroidism on metabolism and cardiovascular risks.
To evaluate potential gender-speciﬁc effects of subclinical
thyroid dysfunction, we compared the blood pressure, BMI, FPG, TC,
HDL-C, LDL-C, and TG levels among male and female subjects with
subclinical thyroid hypo/hyperthyroidism. In subjects with
subclinical hyperthyroidism, men had lower BMI, systolic blood
pressure, TC, TG, and HDL-C, as compared with women. In contrast,
no signiﬁcant differences, with the exception of TC, were observed
between male and female subjects with subclinical hypothy-
roidism. Therefore, the potential effect of subclinical thyroid
dysfunction on MetS, especially subclinical hyperthyroidism, could
vary according to gender.
There are some limitations to this study. First, as this is a cross-
sectional study, a cause and effect relationship between subclinical
thyroid dysfunction and metabolic variables could not be deter-
mined. Second, the number of subjects was too small to stratify the
TSH levels in those with subclinical thyroid dysfunction; therefore,
we could not analyze the association between metabolic variables
and level of TSH.Table 2
Gender differences in elderly subjects with subclinical hypothyroidism
Variable Male
(n¼ 51)
Female
(n¼ 80)
p
Age (yr) 72.0 4.1 70.6 4.9 0.096
Body mass index (kg/m2) 23.2 3.2 24.2 3.4 0.128
Systolic blood pressure (mm Hg) 136.6 24.9 144.8 28.6 0.096
Diastolic blood pressure (mm Hg) 75.0 12.0 76.1 14.8 0.675
Total cholesterol (mg/dL) 200.2 38.1 223.5 43.7 0.002
LDL cholesterol (mg/dL) 131.3 31.7 134.1 46.2 0.702
HDL cholesterol (mg/dL) 42.0 12.0 52.3 17.7 <0.001
Triglycerides (mg/dL) 145.0 93.2 150.7 103.3 0.749
Fasting blood glucose (mg/dL) 109.1 39.1 105.7 26.4 0.554
Number of metabolic syndrome criteria 1.9 1.2 1.9 1.1 0.704
TSH (mIU/mL) 8.6 6.4 8.4 6.1 0.864
HDL¼ high-density lipoprotein; LDL¼ low-density lipoprotein; TSH¼ thyroid-
stimulating hormone.In conclusion, subclinical thyroid dysfunction is not an
uncommon disease among the elderly, especially in women, and
about one-third of them had MetS.References
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